Panacos Pharmaceuticals
Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.
Market cap
$322k
Enterprise value
$322k
Share price
$0.00 PANC
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$20.0m | Post IPO Debt | ||
| Total Funding | 000k | ||
Great Point Partners(exited)
William Harris Investors(exited)
Novo Holdings(exited)
Mitsui Global Investment(exited)
Lakeview Capital Management(exited)
Ampersand Capital Partners(exited)
Pappas Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.